Form 4: GE HealthCare CEO Peter Arduini Reports Stock Transactions
SEC Form 4 Filing
Peter Arduini, CEO of GE HealthCare Technologies Inc., reports the withholding of shares for tax obligations and the award of restricted stock units and an employee stock option.
Summary
- On March 1, 2024, Peter Arduini, the President and CEO of GE HealthCare Technologies Inc., reported transactions involving the company's stock.
- 4,444 shares of common stock were withheld to satisfy tax obligations related to the vesting of restricted stock units at a price of $91.28 per share.
- Arduini was also awarded 36,399 restricted stock units, which will vest in three tranches: 33% on September 1, 2025, 33% on September 1, 2026, and 34% on September 1, 2027, subject to certain conditions.
- Each restricted stock unit represents the right to receive one share of GE HealthCare common stock at settlement.
- Additionally, Arduini received an employee stock option for 103,527 shares, which will become exercisable in three tranches: 33% on September 1, 2025, 33% on September 1, 2026, and 34% on September 1, 2027, subject to certain conditions.
- Following these transactions, Arduini beneficially owns 113,200 shares of common stock and has options for 103,527 shares.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine filing of stock transactions. The awards suggest confidence in the company's future, but the tax withholding is a standard procedure.
Positives
- The award of restricted stock units and stock options to the CEO aligns his interests with those of the shareholders, incentivizing long-term performance.
- The vesting schedule of the awards encourages continued service and commitment to the company's success.
Future Outlook
The restricted stock units and stock options vest over a three-year period, suggesting a long-term commitment from the CEO.
Industry Context
Executive compensation packages often include stock options and restricted stock units to align management's interests with shareholder value. This filing reflects a standard practice in publicly traded companies.
Comparison to Industry Standards
- Comparing GE HealthCare's executive compensation structure to peers like Siemens Healthineers or Philips would provide a better understanding of whether the compensation is in line with industry standards.
- Benchmarking the vesting schedules and equity grant sizes against similar companies can reveal if GE HealthCare's approach is competitive in attracting and retaining top talent.
- Analyzing the ratio of stock-based compensation to overall compensation for GE HealthCare's executives compared to industry averages can offer insights into the company's emphasis on equity incentives.
Stakeholder Impact
- Shareholders may view the equity awards positively as they align management's interests with the company's long-term performance.
- Employees may be motivated by the fact that executives are also incentivized through stock ownership.
Key Dates
| Date | Description |
|---|---|
| 03/01/2024 | Date of transactions: withholding of shares for tax obligations and award of restricted stock units and employee stock option. |
| 03/01/2024 | Date employee stock option becomes exercisable. |
| 03/05/2024 | Date of signature by attorney-in-fact. |
| 09/01/2025 | First vesting date (33%) for restricted stock units and employee stock option. |
| 09/01/2026 | Second vesting date (33%) for restricted stock units and employee stock option. |
| 09/01/2027 | Final vesting date (34%) for restricted stock units and employee stock option. |
| 03/01/2034 | Expiration date of employee stock option. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.